Virtual Executive Roundtable: Ben Osborn, Country Manager, Pfizer UK

The currency of health: a critical driver of investment and recovery/time to build back stronger

The aim of this roundtable is to explore and understand the impact of UK Health on investment and UK global attractiveness and how health of the nation is integral for stimulating regional growth.  Pfizer’s Health and Wealth work illustrates both the opportunities and challenges of the pandemic and demonstrates how public health is an essential pillar of infrastructure and productivity in the future.

Guest speakers will join Ben Osborn for an enlightening forward looking discussion.  Mark Gregory, Chief Economist, EY, will share findings of the UK attractiveness survey and highlights  the role of health in contributing to the UK’s place iin the world post Brexit and post-pandemic.  Dr Jonathan Pearson-Stuttart will explore parameters of the new Health Index and relevance to the business community.

By way of background, our executive Roundtable series regularly features some of the world’s leading business executives who we invite to lead a discussion for a group of around 25 senior business leaders on key issues of importance to British and American business.  The event provides a valuable opportunity for dialogue amongst global business and government leaders.  This event is made possible with support from Willis Towers Watson.


Ben Osborn,
Managing Director and Country Manager, Pfizer UK

After graduating from Leeds University Ben joined Pfizer in 1998, where his career has taken him through a variety of leadership roles both in the UK and internationally.

In 2012, Ben became UK Head of Pfizer Oncology where he was involved in shaping cancer policy through his work with government, PAGs and as a co-chair of the industry body’s cancer group. He also sat on the ‘NHS Molecular Diagnostics in Cancer working group’ and the South London Academic Health Science Network as the industry representative.

More recently Ben was the Chief Marketing Officer across Europe, Japan, Korea and ANZ where he led the digital transformation of the commercial organisation and innovative partnerships across the sector. He is passionate about organisational culture and purpose to ensure patients benefit from breakthrough innovation and science. He is now the UK Country Manager and Managing Director for Pfizer UK, leading the organisation through unprecedented times of opportunity to bring science, data and technology together to transform healthcare.

Ben is married to Nicola and they have three children. He’s also a keen runner competing as often as time allows.


Mark Gregory,
Chief Economist, EY

A leading voice on the UK economy, Mark Gregory is the Chief Economist at EY in the UK, providing knowledge, analysis and insight to help clients understand the economic environments in which they operate.

With over 25 years of experience in more than 40 countries, he is a business economist and an advisor to governments and industry on economics, policy and regulation.

Mark is the sponsoring partner at Ernst & Young – United Kingdom for the UK Economics for Business Program, which includes the EY ITEM Club, one of the UK’s leading independent economic forecasters, and the EY renowned UK Attractiveness program, the leading independent voice on Foreign Direct Investment.

In addition, he was a 2016, 2017 and 2018 LinkedIn ‘Top UK Voice.’ This award recognizes those individuals whose words have launched countless high-quality conversations locally, and globally, on the platform. He earned an MSc and a BA in Economics from The University of Manchester.


Dr Jonathan Pearson-Stuttard

Dr Jonathan Pearson-Stuttard, FRSPH is a Public Health Physician and Epidemiologist at Imperial College London, Head of Health Analytics at Lane Clark & Peacock Vice Chair of the Royal Society for Public Health.

Jonny was Editor-in-Chief of the Chief Medical Officer’s 2018 Report ‘Health 2040; Better Health Within Reach’ which recommended the development of a composite Health Index. This was published by the ONS in 2020 and Jonny remains on the advisory group and closely involved. His book, co-authored with Dame Sally Davies’ – Whose health is it, anyway? – builds on the links between health and wealth that led to the index recommendation and repositions health as our most untapped opportunity for prosperity and happiness in the 21st century.

In his research work, Jonny has been awarded multiple competitive clinical-academic research positions from the NIHR and the Wellcome Trust. His research has two main streams spanning non-communicable disease epidemiology. First, using big data and simulation modelling of health, economic and inequality outcomes to inform public health policy. Second, he investigates the increasing multimorbidity and diversification of outcomes in patients with chronic diseases such as diabetes.

Jonny is on several advisory boards and speaks regularly on a range of topics across health.


Dame Sally Davies
UK Special Envoy on Antimicrobial Resistance

Before this, she was Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010.

Dame Sally advocates globally on AMR. She has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016. She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR. Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016.

Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016 and has led delegations to a range of WHO summits and forums since 2004.

She is currently a non-executive director on the boards of: The Institute for Health Metrics and Evaluation; Genomics England Ltd; The Blavatnik School of Government, University of Oxford; The Clinton Health Access Initiative; and UK Research & Innovation. She was formerly on the boards of Cumberland Lodge and Ashridge Business School.

From 2004-2016, Dame Sally was the Chief Scientific Adviser (CSA) for the Department of Health (DH), where she was actively involved in NHS R&D from its establishment and founded the National Institute for Health Research (NIHR).

Dame Sally received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015.

BAB Host & Moderator

Nick Dunlop,
Managing Director, Global Solutions, Willis Towers Watson

Nick has been engaged in managing and trading complex insurance risks at Willis Towers Watson since 1981. His career has predominantly involved advising North American domiciled corporations and creating placement solutions for these organisations in the Global Markets.  He has led Property Risk practices in London, New York and Toronto.

Nick is now Managing Director with responsibility for growth leadership across all Willis Towers Watson Industry Segments worldwide.

In addition to his responsibilities within Willis Towers Watson Nick is Chairman of the Non–Marine Executive of the London International Insurance Brokers Association (LIIBA), a main board director of BritishAmerican Business and Court Assistant and Chairman of the Livery Committee of the Worshipful Company of Insurers.

BAB Host & Moderator

Duncan Edwards,
CEO, BritishAmerican Business

Duncan Edwards is the chief executive of BritishAmerican Business, the leading transatlantic trade organization of some 450 companies, which has an ongoing mission to support policies which protect and enhance the environment for trade and investment in, and between, the USA and the UK.  He is a regular contributor to policy debates and is a frequent media commentator on US UK relations.

Prior to this, Duncan Edwards spent over 30 years as a media executive in London and New York of which 27 years were spent at the Hearst Corporation.  His most recent role at Hearst was president and ceo of the international magazine and digital media company, a business with activities in more than 60 countries which he led to record levels through acquisition and organic growth.

A British citizen, he currently lives in New York and Connecticut where he can often be found on long runs in the hills.



Thursday 25th February 2021


3:00 pm – 4:00 pm GMT / 10:00 am – 11:00 am EST


Zoom – link will be sent to invited guests